
UC Irvine Health
Video Player is loading.
ASCO® 2024 Insights: "Study EV-103 - Neoadjuvant Enfortumab Vedotin in Cisplatin-Ineligible MIBC Patients"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Nataliya Mar
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Nataliya Mar
Comments 0
Login to view comments.
Click here to Login